# Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector

Study · id `cardio:ct-nct03279484` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03279484](<https://clinicaltrials.gov/study/NCT03279484>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03279484

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 317 participants.

## Technical summary

Registry record NCT03279484. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-24 (actual); primary completion 2019-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 317 participants (planned count; ClinicalTrials.gov record NCT03279484, source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)
- Started: 2017-11-24 (actual) (ClinicalTrials.gov record NCT03279484, source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)
- Primary completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03279484, source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)
- Completion: 2022-03 (anticipated) (ClinicalTrials.gov record NCT03279484, source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)
- Countries: France; Germany; Italy; Netherlands; Portugal; Spain (ClinicalTrials.gov record NCT03279484, source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03279484-2019-09-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Electrical Performances Evaluation of Navigo Leads Equipped With IS4 Connector
- Acronym: NAVIGATOR
- Condition: Arrythmia, Implatable Cardioverter Defibrillation, Lead
- Intervention (Device): NAVIGO 4LV lead implant
- Lead sponsor: MicroPort CRM
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: MicroPort CRM (`cardio:org-microport-crm`)

## Provenance

Content hash: db895c3743b857bde62254697a9c6188887e0f930b3983bf1694d1079f2f9892
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
